Table 2. Correlations between DDR2 expression and other important clinicopathological parameters in urothelial carcinomas.
Parameter | Category | Upper Carcinoma | Urinary | Tract | Urothelial | Urinary | Bladder | Urothelial | Carcinoma |
---|---|---|---|---|---|---|---|---|---|
Case No. | DDR2 Expression | p-value | Case No. | DDR2 Expression | p-value | ||||
Low | High | Low | High | ||||||
Gender | Male | 158 | 81 | 77 | 0.664 | 216 | 110 | 106 | 0.667 |
Female | 182 | 89 | 93 | 79 | 38 | 41 | |||
Age (years) | < 65 | 138 | 67 | 71 | 0.659 | 121 | 63 | 58 | 0.587 |
≥ 65 | 202 | 103 | 99 | 174 | 85 | 89 | |||
Tumor location | Renal pelvis | 141 | 63 | 78 | 0.250 | − | − | − | − |
Ureter | 150 | 80 | 70 | − | − | − | − | ||
Renal pelvis & ureter | 49 | 27 | 22 | − | − | − | − | ||
Multifocality | Single | 278 | 137 | 141 | 0.574 | − | − | − | − |
Multifocal | 62 | 33 | 29 | − | − | − | − | ||
Primary tumor (T) | Ta | 89 | 60 | 29 | < 0.001* | 84 | 63 | 21 | < 0.001* |
T1 | 92 | 58 | 34 | 88 | 43 | 45 | |||
T2-T4 | 159 | 52 | 107 | 123 | 42 | 81 | |||
Nodal metastasis | Negative (N0) | 312 | 161 | 151 | 0.049* | 266 | 136 | 130 | 0.319 |
Positive (N1-N2) | 28 | 9 | 19 | 29 | 12 | 17 | |||
Histological grade | Low grade | 56 | 35 | 21 | 0.041* | 56 | 44 | 12 | < 0.001* |
High grade | 284 | 135 | 149 | 239 | 104 | 135 | |||
Pattern of Invasion | Nodular | 200 | 124 | 76 | < 0.001* | 137 | 87 | 50 | < 0.001* |
Trabecular | 58 | 21 | 37 | 82 | 37 | 45 | |||
Infiltrative | 82 | 25 | 57 | 76 | 24 | 52 | |||
Vascular invasion | Absent | 234 | 142 | 92 | < 0.001* | 246 | 135 | 111 | < 0.001* |
Present | 106 | 28 | 78 | 49 | 13 | 36 | |||
Perineural invasion | Absent | 321 | 166 | 155 | 0.009* | 275 | 142 | 133 | 0.062 |
Present | 19 | 4 | 15 | 20 | 6 | 14 | |||
Mitotic rate (per 10 high power fields) | < 10 | 173 | 96 | 77 | 0.039* | 139 | 92 | 47 | < 0.001* |
>= 10 | 167 | 74 | 93 | 156 | 56 | 100 |
Statistically significant.